Multiple myeloma patients have more treatment options than ever before but how are side effects and toxicities managed? Join us for our next Myeloma Answers Now program on Friday, August 7th at 1 pm PT/4 pm ET.
Host and patient advocate Cindy Chmielewski will talk to Dr. Cesar Rodriguez from Wake Forest Baptist Health and Dr. Natalie S. Callander from the University of Wisconsin School of Medicine and Public Health about new myeloma drugs like belamaf, ide-cel, CAR-T, and selinexor. Together, they will discuss how experts are managing toxicities from these new treatment options. They will also be joined by multiple myeloma patient, Yolanda Brunson-Sarrabo, who will share her patient story and experiences. Send your questions in advance to email@example.com
Hosts and Guests
Patient Advocate and Mentor
Cesar Rodriguez MD
Myeloma Specialist, Wake Forest Baptist Health
Natalie S. Callander MD
Associate Professor, University of Wisconsin School of Medicine and Public Health
Yolanda Brunson-Sarrabo CPT- NASM
Multiple Myeloma Patient and Author/Blogger
Already have an account? Login and register
Friday, August 7, 2020
What new essential thrombocythemia (ET) treatment options, including clinical trials and drug approvals, are available? Are there delays in treating ET because of COVID-19? What diet or supplements work for managing essential thrombocythemia? Join us for an MPN Answers Now program on August 7th at 11:30 am PT/2:30 pm ET.
Tuesday, August 11, 2020
Register for our next Answers Now program on Tuesday August 11th at 9:30 am PT/12:30 pm ET. Esther Schorr will be live with running expert Kenny Capps, who is living with multiple myeloma, and cancer exercise specialist Cathy Skinner from Thrivors, Inc.
Wednesday, August 12, 2020
Do you have chronic lymphocytic leukemia questions to ask? Join us Wednesday, Aug 12th at 1:00 pm PT/4:00 pm ET and our CLL expert will answer your questions!